PDCD1 and neoplasm: The ability of tumour cells to evade immune surveillance and facilitate tumour survival is due to their expression of surface molecules that interact with immune cells to maintain normal immune tolerance, which includes the interaction of the immune receptor programmed cell death 1 (PD1) with its tumour-associated ligand PD-L1 [6].